text:
EX-99.1
5
pressreleaseem.txt
PRESS RELEASE
EXHIBIT 99.1
[WORLDWATER & SOLAR TECHNOLOGIES CORP. LOGO]
FOR RELEASE ON 1/28/08 AT 3:01 A.M. EST
WORLDWATER & SOLAR TECHNOLOGIES ANNOUNCES
COMPLETION OF ENTECH MERGER
TRANSACTION EXPEDITED BY QUERCUS TRUST
EWING, N.J. - January 28, 2008 - WorldWater & Solar Technologies Corp. (OTC
BB: WWAT.OB), developer and marketer of proprietary high-power solar systems,
today announced that it has closed the merger with ENTECH, Inc. of Keller,
Texas. This transaction was made possible through agreement with one of
WorldWater's largest investors, the Quercus Trust (Quercus). Quercus exchanged
19.7 million of its common shares of WorldWater for 19,700 shares of convertible
preferred stock and supplied WWAT with a $6 million bridge loan. The 19.7
million common shares and the bridge loan were subsequently utilized to complete
the ENTECH merger.
Pursuant to the exchange agreement, once a shareholders meeting is held and
additional common shares are authorized, a subsequent exchange with Quercus will
be implemented. As a result, Quercus will receive 19.7 million common shares in
exchange for the 19,700 shares of convertible preferred stock previously issued.
"The Quercus Trust, which has been an investor in our company since last
spring, has demonstrated its strong commitment to both WorldWater and ENTECH by
making this transaction possible on an expedited basis", said Quentin T. Kelly,
Chairman and CEO. "As our investors know, the merger with ENTECH, 19 months in
the making, paves the way for our company to provide 20x concentrator PV systems
to the U.S. and international markets at costs among the lowest of all solar
suppliers, including thin film manufacturers. Quercus made it possible to move
forward without further delays, allowing us to take advantage of the many
opportunities now on the table across the globe. With solar energy taking on
greater significance both in the U.S. and overseas - and oil prices at near
all-time highs - we simply could not wait any longer to merge our two companies
and leverage the resulting synergies. Quercus enabled this to happen".
Dr. Walter Hesse, CEO of ENTECH, commented, "This is terrific. Now ENTECH
and WorldWater & Solar Technologies can proceed with the production of our 20x
concentrator lines. Together with WorldWater, we will be able to supply 'solar
farms' throughout the world with electricity production at costs and
efficiencies that we believe change the current economics of solar power -
making it affordable to millions".
ABOUT WORLDWATER & SOLAR TECHNOLOGIES CORP:
WorldWater & Solar Technologies Corporation is a full-service, international
solar electric engineering and water management company with unique,
high-powered and patented solar technology that can not only generate and
distribute electricity, but can drive 1000 horsepower motors and pumps from
sunshine independently or in conjunction with the electric grid, providing
solutions to a broad spectrum of the world's electricity and water supply
problems. For more information about WorldWater & Solar Technologies Corp.,
visit the website at www.worldwater.com.
ABOUT ENTECH, INC:
ENTECH provides advanced concentrator solar energy technology for a variety of
applications, ranging from solar power arrays for spacecraft and terrestrial
implementation to day lighting systems for commercial buildings. The company's
patented solar power systems produce electricity from sunlight for applications
on Earth (terrestrial power) and in space (spacecraft power). ENTECH's arched
Fresnel lenses capture sunlight and focus it onto small solar cells, thereby
reducing electricity costs compared to conventional flat-plate (planar) solar
energy approaches. Additional information can be found at
http://www.entechsolar.com.
FORWARD LOOKING STATEMENTS:
Except for historical information contained herein, this document contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements involve known and unknown risks
and uncertainties that may cause the Company's actual results or outcomes to be
materially different from those anticipated and discussed herein. Further, the
Company operates in industries where securities values may be volatile and may
be influenced by regulatory and other factors beyond the Company's control.
Other important factors that the Company believes might cause such differences
are discussed in the risk factors detailed in the Company's 10-KSB and its
quarterly reports on Form 10-QSB both as filed with the Securities and Exchange
Commission, which include the Company's cash flow difficulties, dependence on
significant customers, and rapid development of technology, among other risks.
In assessing forward-looking statements contained herein, readers are urged to
carefully read all cautionary statements contained in the Company's filings with
the Securities and Exchange Commission.
###
WORLDWATER & SOLAR TECHNOLOGIES CONTACT: Jessie Sullivan: (609) 818-0700 ext. 20
JSullivan@worldwater.com
PRESS CONTACT: Amy Copeman (609) 818-0700 ext. 58
ACopeman@worldwater.com
INVESTOR RELATIONS CONTACT: Chris Witty (646) 438-9385
cwitty@darrowir.com

text: WORLDWATER & SOLAR TECHNOLOGIES CORP.

text: WORLDWATER & SOLAR TECHNOLOGIES

text: ENTECH

text: WorldWater & Solar Technologies Corp.

text: ENTECH, Inc.

text: ENTECH

text: ENTECH

text: Quentin T. Kelly

text: ENTECH

text: Walter Hesse

text: ENTECH

text: ENTECH

text: WorldWater & Solar Technologies

text: WorldWater & Solar Technologies

text: WorldWater & Solar Technologies Corp.

text: ENTECH

text: ENTECH

text: ENTECH

text: WORLDWATER & SOLAR TECHNOLOGIES


dataset: buster

text:
EX-99.1
4
d146556dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Stone Point Capital and Insight Partners Complete Acquisition of CoreLogic
Irvine, CA, June 4, 2021
- CoreLogic
®
, a leading global property information, analytics and
data-enabled solutions provider, today announced the completion of its acquisition by funds managed by Stone Point Capital and Insight Partners for $80 per share in cash. CoreLogic's common stock has ceased trading on the New York Stock
Exchange.
CoreLogic will continue to be headquartered in Irvine, California, and the Company's management team led by President and CEO Frank
Martell will remain in place and continue to operate CoreLogic as a private company.
Frank Martell said, "Today marks a major milestone in
CoreLogic's history as we move to capture the many opportunities in front of us to accelerate our growth and transformation as a privately held firm. The entire team is excited and looking forward to working closely with Stone Point and Insight
Partners to build on our record financial and operating performance and deliver solutions that help millions of people find, buy, and protect their homes each year".
Chuck Davis, CEO of Stone Point Capital, said, "Stone Point is thrilled to work with the CoreLogic leadership team to support the Company's next
phase of growth. CoreLogic is a mission-critical vendor and data provider across industry sectors in which Stone Point has specialized over the past 20 years, including mortgage, residential real estate and P&C insurance. We believe our
financial services domain expertise and our partnership with the management team can accelerate CoreLogic's momentum as it delivers new innovative solutions to its customers".
Deven Parekh, Managing Director at Insight Partners, said, "We are excited to partner with the talented team at CoreLogic as the company continues to
innovate across the real estate ecosystem. Insight Partners has a strong track record of partnering with market-transforming companies like CoreLogic, and we look forward to active involvement in this next chapter in its evolution".
Evercore acted as financial advisor to CoreLogic and Skadden, Arps, Slate, Meagher & Flom LLP acted
as the Company's legal advisor. J.P. Morgan Securities LLC and Wells Fargo Securities, LLC acted as financial advisors to Stone Point Capital and Insight Partners. Kirkland & Ellis acted as legal advisor to Stone Point Capital and
Willkie Farr and Gallagher acted as legal advisor to Insight Partners.
About CoreLogic
CoreLogic, a leading provider of property insights and solutions, promotes a healthy housing market and thriving communities. Through its enhanced property
data solutions, services and technologies, CoreLogic enables real estate professionals, financial institutions, insurance carriers, government agencies and other housing market participants to help millions of people find, buy, and protect their
homes. For more information, please visit www.corelogic.com.
About Stone Point Capital
Stone Point is an investment firm based in Greenwich, CT, with approximately $30 billion of assets under management. Stone Point targets investments in
companies in the global financial services industry and related sectors. The firm invests in a number of alternative asset classes, including private equity through its flagship Trident Funds. Stone Point also manages both liquid and private
credit funds and managed accounts. In addition, Stone Point Capital Markets supports our firm, portfolio companies and other clients by providing dedicated financing solutions. For more information, please visit
www.stonepoint.com
.
About Insight Partners
Insight Partners is a
leading global venture capital and private equity firm investing in
high-growth
technology and software ScaleUp companies that are driving transformative change in their industries. Founded in 1995, Insight
Partners has invested in more than 400 companies worldwide and has raised through a series of funds more than $30 billion in capital commitments. Insight's mission is to find, fund, and work successfully with visionary executives,
providing them with practical,
hands-on
software expertise to foster long-term success. Across its people and its portfolio, Insight encourages a culture around a belief that ScaleUp companies and growth
create opportunity for all. For more information on Insight and all its investments, visit
insightpartners.com
or follow us on Twitter
@insightpartners
.
CoreLogic Contacts:
Investors:
Dan Smith
703-610-5410
danlsmith@corelogic.com
Media:
Sard
Verbinnen & Co.
George Sard/Robin Weinberg/Devin Broda
CoreLogic-SVC@SARDVERB.com
Stone Point Capital Contact
:
Mary Catherine Manin
(203)
862-3126
mmanin@stonepoint.com
Insight Partners Contact
:
Nikki Parker
(571)
353-4237
nparker@insightpartners.com

label: fund

text: Stone Point Capital

override: fund

text: Insight Partners

label: organization

text: CoreLogic

text: CoreLogic

text: Stone Point Capital

text: Insight Partners

text: CoreLogic

text: CoreLogic

text: CoreLogic

text: CoreLogic

text: Stone Point

text:
Insight
Partners

label: person

text: Chuck Davis

text: Stone Point

text: Stone Point

text: CoreLogic

text: CoreLogic

text: Stone Point

text: CoreLogic

text: Deven Parekh

text: Insight Partners

text: CoreLogic

text: Insight Partners

text: CoreLogic

text: Evercore

text: CoreLogic

text: J.P. Morgan Securities LLC

text: Wells Fargo Securities, LLC

text: Stone Point

text: Insight Partners

text: Kirkland & Ellis

text: Stone Point

text: Willkie Farr and Gallagher

text: Insight Partners

text: CoreLogic

text: CoreLogic

text: CoreLogic

text: Stone Point

text: Stone Point

text: Stone Point

text: Stone Point

text: Stone Point

text: Insight Partners

text: Insight Partners

text:
Insight
Partners

text: CoreLogic

text: Stone Point

text: Insight Partners

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
4
a15-14256_10ex99d1.htm
EX-99.1
Exhibit 99.1
July 1, 2015
CyrusOne Announces Closing of Cervalis Acquisition
New York Metro Data Center Operator Significantly Enhances Company's Geographic and Customer Diversification and Strengthens Product Portfolio
DALLAS-(BUSINESS WIRE)- CyrusOne Inc. ("CyrusOne") (NASDAQ:CONE) announced today that it has closed the previously announced acquisition of Cervalis Holdings LLC ("Cervalis"), a privately-held operator of four data center facilities and two work area recovery facilities (collectively, the "Facilities") serving the New York metropolitan area. The transaction expands CyrusOne's existing portfolio to 31 data centers across 12 distinct markets (10 cities in the U.S., London and Singapore).
"We are excited about welcoming Cervalis into the CyrusOne family, as Mike Boccardi and his team have created the premier financial services data center platform in the New York Metro area", said Gary Wojtaszek, president and chief executive officer of CyrusOne. "Cervalis is highly complementary to our existing business, strengthening our geographic footprint by establishing a presence in a very important East Coast market and providing an attractive portfolio of enterprise customers, including some of the largest financial services companies in the world".
Pursuant to the terms of the transaction, a subsidiary of CyrusOne acquired Cervalis for approximately $400 million, excluding transaction-related expenses, in an all cash transaction. The acquisition was financed through proceeds from the Company's recent common stock and senior notes offerings as well as drawings under its recently amended senior unsecured credit facility.
Transaction Highlights
The transaction adds four Tier 3+ data center facilities and two standalone work area recovery facilities serving the New York metropolitan region into CyrusOne's existing data center platform. The Cervalis Facilities currently comprise more than 500,000 gross square feet of space, including more than 130,000 colocation square feet and over 100,000 square feet of work area recovery space.
"We are looking forward to joining the CyrusOne team and leveraging the combined company's strength to accelerate the growth trajectory of the business", said Michael Boccardi, president and chief executive officer of Cervalis. "There is a significant benefit in being able to offer our financial services and other enterprise customers the opportunity to grow outside of the New York Metro area through CyrusOne's platform of interconnected data centers".
In fiscal year 2014 and the first quarter of 2015, Cervalis generated revenue of $69 million and $20 million, respectively, with approximately two-thirds being derived from colocation services, and the remainder from interconnection, managed services, and work area recovery products. As of the end of the first quarter of 2015, 78% of the colocation square feet within the Cervalis Facilities was utilized. In addition to the currently available raised floor space, it currently has capacity under shell to deliver an incremental 50,000 colocation square feet.
The transaction is expected to provide additional benefits to CyrusOne, including the following:
·
Enhanced Geographic Diversification:
The combination greatly enhances CyrusOne's geographic diversification, establishing a presence in the Northeast with the addition of a platform that includes four data centers in the New York metropolitan market.
·
Access to a High Quality Enterprise Customer Base:
Cervalis serves approximately 220 enterprise customers, with a particular niche servicing some of the world's largest financial institutions, including several Fortune 1000 companies. Approximately two-thirds of its first quarter 2015 revenue came from customers within the financial services industry.
·
Strengthened Product Portfolio:
The transaction provides a set of interconnected data centers in one of the world's largest internet hubs, further enhancing the attractiveness of CyrusOne's National IX platform. Access to a high-end managed services offering provides a platform that can be selectively leveraged across CyrusOne's existing customer base to accelerate growth.
Financial Impact
The acquisition is expected to be accretive to Normalized FFO per diluted share and unit in the second half of 2015. There is potential additional accretion in 2016 based on lease up of existing inventory and synergies. The Company will provide updated guidance for the year on its second quarter 2015 earnings call.
Financial and Legal Advisors
Morgan Stanley and Allen & Company LLC served as financial advisors to CyrusOne, and DLA Piper served as CyrusOne's legal advisor. DH Capital served as the financial advisor to Cervalis and Pillsbury Winthrop Shaw Pittman served as Cervalis' legal advisor.
Safe Harbor
This release contains forward-looking statements regarding future events and our future results that are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, are statements that could be deemed forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which we operate and the beliefs and assumptions of our management. Words such as "expects", "anticipates", "predicts", "projects", "intends", "plans", "believes", "seeks", "estimates", "continues", "endeavors", "strives", "may", variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our businesses, and other characterizations of future events or circumstances are forward-looking statements. Examples of forward-looking statements include, but are not limited to: (i) statements about the benefits of CyrusOne's acquisition of the Facilities, including future financial and operating results, enhanced utilization of the Facilities, expected cost savings, enhanced revenues and accretion to reported earnings and funds from operations that may be realized from the acquisition; (ii) statements of plans, objectives and expectations of CyrusOne or its management, including the expected timing of completion of the transaction; (iii) statements of future economic performance; and (iv) statements of assumptions underlying such statements and other statements that are not historical facts. Readers are cautioned these forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially and adversely from those reflected in the forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i) the risk that the Facilities will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; (ii) the risk that the expected increased revenues, funds from operations and net income may not be fully realized or may take longer to realize than expected; (iii) the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; and (iv) disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers. More information on potential risks and uncertainties related to our business is available in our recent filings with the SEC, including CyrusOne's Form 10-K report, Form 10-Q reports, and Form 8-K reports. Actual results may differ materially and adversely from those expressed in any forward-looking statements. We undertake no obligation to revise or update any forward-looking statements for any reason.
About CyrusOne
CyrusOne (NASDAQ: CONE) specializes in highly reliable enterprise-class, carrier-neutral data center properties. The company provides mission-critical data center facilities that protect and ensure the continued operation of IT infrastructure for nearly 900 customers, including nine of the Fortune 20 and over 160 of the Fortune 1000 or equivalent-sized companies.
CyrusOne's data center offerings provide the flexibility, reliability, and security that enterprise customers require and are delivered through a tailored, customer service-focused platform designed to foster long-term relationships. CyrusOne's National IX platform provides robust connectivity options to drive revenue, reduce expenses, and improve service quality for enterprises, content, and telecommunications companies. CyrusOne is committed to full transparency in communication, management, and service delivery throughout its more than 30 data centers worldwide.
CyrusOne Inc.
Investors
Michael Schafer, 972-350-0060
investorrelations@cyrusone.com
Media
Jacob Smith, 513-671-3811
cyrusone@gyro.com

text: CyrusOne

text: Cervalis

text: CyrusOne Inc.

text: CyrusOne

text: Cervalis Holdings LLC

text: Cervalis

text: CyrusOne

text: Cervalis

text: CyrusOne

text: Gary Wojtaszek

text: CyrusOne

text: Cervalis

text: CyrusOne

text: Cervalis

text: CyrusOne

text: Cervalis

text: CyrusOne

text: Michael Boccardi

text: Cervalis

text: CyrusOne

text: Cervalis

text: Cervalis

text: CyrusOne

text: CyrusOne

text: Cervalis

text: CyrusOne

text: CyrusOne

text: Morgan Stanley

text: Allen & Company LLC

text: CyrusOne

text: DLA Piper

text: CyrusOne

text: DH Capital

override: organization

text: Cervalis

text: Pillsbury Winthrop Shaw Pittman

text: Cervalis

text: CyrusOne

text: CyrusOne

text: CyrusOne

text: CyrusOne

text: CyrusOne

text: CyrusOne

text: CyrusOne

text: CyrusOne

text: CyrusOne Inc.


text:
EX-99.1
2
exhibit1.htm
EX-99.1
EX-99.1
C O L E
COLE CREDIT PROPERTY TRUST II, INC.
December 6, 2005
Contact:
John H. Lotka, Chief Marketing Officer
602-778-8739
For Immediate Release:
Cole Credit Property Trust II, Inc. announces the acquisition of a property located in Alabama,
leased to Lowe's, and a property located in Georgia, leased to CVS
On December 1, 2005, wholly-owned subsidiaries of the operating partnership of Cole Credit Property
Trust II, Inc. acquired (i) an approximately 95,170 square foot single-tenant retail building on an
approximately 16.70 acre site located in Enterprise, Alabama, which is 100% leased to Lowe's Home
Centers, Inc., which is a wholly-owned subsidiary of Lowe's Companies, Inc. ("Lowe's"), through the
initial lease term, which expires on April 30, 2015 and (ii) an approximately 10,125 square foot
single-tenant retail building on an approximately 1.19 acre site located in Alpharetta, Georgia,
which is 100% leased to Mayfield CVS, Inc., which is a wholly-owned subsidiary of CVS Corporation
("CVS"), through the initial lease term, which expires on January 31, 2019.
About Lowe's and CVS
Lowe's operates over 1,150 stores in 49 states. Lowe's has a Standard & Poor's credit rating of
"A+" and the company's stock is publicly traded on the New York Stock Exchange under the ticker
symbol "LOW".
CVS operates over 5,000 stores in 36 states. CVS has a Standard & Poor's credit rating of "A-" and
the company's stock is publicly traded on the New York Stock Exchange under the ticker symbol
"CVS".
About Cole Credit Property Trust II, Inc.
Cole Credit Property Trust II, Inc. is a Maryland corporation that intends to qualify as a real
estate investment trust beginning with the taxable year ending December 31, 2005. The investment
objectives of Cole Credit Property Trust II, Inc. are to provide current income, preservation and
return of capital and growth in the value of its investments.
This release may contain forward-looking statements relating to the business and financial outlook
of Cole Credit Property Trust II, Inc. that are based on our current expectations, estimates,
forecasts and projections and are not guarantees of future performance. Actual results may differ
materially from those expressed in these forward-looking statements and you should not place undue
reliance on any such statements. A number of important factors could cause actual results to differ
materially from the forward-looking statements contained in this release. Such factors include
those described in the Risk Factors sections of the prospectus for the offering of equity of Cole
Credit Property Trust II, Inc. Forward-looking statements in this document speak only as of the
date on which such statements were made and we undertake no obligation to update any such
statements that become untrue because of subsequent events. We claim the safe harbor protection for
forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
2555 E. Camelback Road, Suite 400
Phoenix, AZ 85016
602-778-8700

text: COLE CREDIT PROPERTY TRUST II, INC.

text: John H. Lotka

text: Cole Credit Property Trust II, Inc.

text:
Cole Credit Property
Trust II, Inc.

text: Cole Credit Property Trust II, Inc.

text: Cole Credit Property Trust II, Inc.

text: Cole Credit Property Trust II, Inc.

text: Cole Credit Property Trust II, Inc.

text:
Cole
Credit Property Trust II, Inc.


text:
EX-99.2
11
ea148089ex99-2_aerocentury.htm
PRESS RELEASE, DATED SEPTEMBER 30, 2021
Exhibit 99.2
AeroCentury Corp. Announces Closing of Securities
Purchase Agreement
PALO ALTO, CALIFORNIA, September 30, 2021 (GLOBE
NEWSWIRE) -- AeroCentury Corp. ("AeroCentury" or the "Company") (NYSE American: ACY), today announced the closing
of the sale of an aggregate 2,870,927 shares of Common Stock of the Company at $3.85 per share, for an aggregate cash purchase price of
approximately $11 million (the "Transaction") pursuant to the Securities Purchase Agreement (the "Securities Purchase
Agreement") between and among Yucheng Hu, Hao Yang, Jing Li, Yeh Ching, Yu Wang, TongTong Ma, Qiang Zhang, Yanhua Li, and Yiyi Huang
(collectively, the "Plan Sponsors") and AeroCentury. The Transaction was previously approved by the U.S. Bankruptcy Court
for the District of Delaware (the "Bankruptcy Court") on August 31, 2021.
Upon consummation of the Transaction, the Plan
Sponsors became holders, of approximately 65% of the outstanding shares of Common Stock of AeroCentury, and AeroCentury completed its
Chapter 11 restructuring process and emerged from its Chapter 11 bankruptcy.
Michael Magnusson, the Company's previous
Chief Executive Officer, said: "We are happy to conclude the Company's Chapter 11 reorganization with the closing of this
$11 million capital investment by Mr. Hu and other investors, which will enable the Company to move forward with no debt and with new
capital resources. Although this can be seen as a new beginning for AeroCentury, I and my group of colleagues that the aviation industry
has come to know for many years as "AeroCentury", will remain in place with the Company's majority-owned subsidiary,
JetFleet Holding Corp., which will continue the legacy regional aircraft business of the Company under the aptly-named "JetFleet"
moniker. With proceeds of the Plan Sponsors' equity investment earmarked to fund the re-start of JetFleet Holding Corp.'s
activities, we are excited to retake our place as a major player in that regional aviation space".
Yucheng Hu, the Company's new Chief Executive
Officer, said: "We are very pleased to complete the Transaction. We look forward to continuing to enjoy a portion of the growth
and development of the Company's legacy aircraft leasing business through our majority stake in the Company's previously wholly-owned
subsidiary, JetFleet Holding Corp., but we will also be opportunistic and look for additional growth investments in the future to diversify
our revenue streams and potential high growth earnings to our shareholders".
The Company and its U.S. subsidiaries previously
filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Court on March 29, 2021. On August 31, 2021, the Bankruptcy Court
confirmed the Company's Plan of Reorganization.
The Bankruptcy Court filings and other information
related to the proceedings are available on a separate website administered by the Company's noticing and claims agent, Kurtzman
Carson Consultants LLC, at https://www.kccllc.net/aerocentury.
Advisors
Morrison & Foerster LLP and Young Conaway
Stargatt & Taylor, LLP acted as legal advisor to the Company, and B Riley Securities, Inc. acted as its financial advisor and investment
banker.
Lewis Brisbois Bisgaard & Smith LLP acted
as the legal advisors to Yucheng Hu, the Plan Sponsor representative.
About AeroCentury Corp.
AeroCentury is an independent global aircraft
lessor and finance company specializing in regional aircraft and related engines..
Forward-Looking Statements
Certain statements made in this release are "forward
looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation
Reform Act of 1995. When used in this press release, the words "estimates", "projected", "expects", "anticipates,"
"forecasts", "plans", "intends", "believes", "seeks", "may", "will,"
"should", "future", "propose" and variations of these words or similar expressions (or the negative versions
of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees
of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important
factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those
discussed in the forward-looking statements. Important factors, among others, are: the ability to manage growth; ability to identify and
integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in
general economic and business conditions; costs or other factors adversely affecting the Company's profitability; litigation involving
patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic.
The forward-looking statements in this press release and the Company's future results of operations are subject to additional risks
and uncertainties set forth under the heading "Factors that May Affect Future Results and Liquidity" in documents filed by
the Company with the Securities and Exchange Commission, including the Company's quarterly reports on Form 10-Q and the Company's
latest annual report on Form 10-K, and are based on information available to the Company on the date hereof. In addition, such risks and
uncertainties include the Company's inability to predict or control bankruptcy proceedings and the uncertainties surrounding the
ability to generate cash proceeds through the sale or other monetization of the Company's assets. The Company undertakes no obligation
to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required
by applicable law. Such information speaks only as of the date of this release.
No Offer or Solicitation
This press release is for informational purposes
only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities
in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities
laws of any such jurisdiction.

text: AeroCentury Corp.

text: AeroCentury Corp.

text: Plan Sponsors

text:
Plan
Sponsors

text: Plan Sponsors

text: Morrison & Foerster LLP

text:
Young Conaway
Stargatt & Taylor, LLP

text: B Riley Securities, Inc.

text: Lewis Brisbois Bisgaard & Smith LLP

text: AeroCentury Corp.


text:
EX-99.1
3
ea148764ex99-1_inmedpharma.htm
PRESS RELEASE, DATED OCTOBER 13, 2021
Exhibit 99.1
NASDAQ: INM
Suite 310-815 W. Hastings St.
Vancouver, BC, Canada V6C 1B4
Tel: +1.604.669.7207
Email: info@inmedpharma.com
www.inmedpharma.com
InMed Pharmaceuticals Completes Acquisition
of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
Vancouver, BC and South San Francisco,
CA - October 13, 2021 -
InMed Pharmaceuticals Inc.
("InMed" or the "Company") (Nasdaq: INM),
a leader in the manufacturing and clinical development of rare cannabinoids, today announced that they have completed the previously announced
acquisition of BayMedica Inc. ("BayMedica"), a private company based in the US specializing in the manufacturing and commercialization
of rare cannabinoids for the health and wellness sector.
Eric A. Adams, President and Chief Executive
Officer of InMed, stated, "We are delighted to close this acquistion and welcome everyone at BayMedica to the InMed team. In the
next several weeks, we will focus on corporate integration, exploring our combined manufacturing know-how and looking to accelerate revenue
growth. BayMedica brings significant expertise and will help strengthen our pharmaceutical drug development efforts as well as position
the Company to become a global leader in the manufacturing of rare cannabinoids".
Shane Johnson, Senior Vice President
and General Manager of BayMedica, stated, "We are very pleased to finalize this transaction and join forces with InMed. Together
we have the capabilities and resources to accelerate our commercial initiatives and expedite the launch of several new cannabinoids products
in the consumer health and wellness sector. The combined technologies in rare cannabinoid manufacturing, including synthetic biology,
chemical synthesis and enzymatic biotransformation (IntegraSyn
TM
), establishes us as a leader in the field".
Acquistion
overview and amended transaction terms:
InMed acquired 100% of BayMedica in exchange for 2.05 million InMed common shares issued
to BayMedica's equity and convertible debt holders, subject to a six-month contractual hold period. The previously announced issuance
of Series A and Series B warrants to acquire 1.6 million common shares was replaced with a cash component of US$1 milllion. The entirety
of this cash consideration will be held in escrow, subject to cancellation, to satisfy certain potential post-closing indemnification
and other claims that InMed may have under the definitive agreement in the six- and twelve-month periods following the closing.
To learn more about the transaction
and hear more about InMed's future developments, please visit our website and view a recent webinar featuring Eric A. Adams and
Shane Johnson.
About
InMed:
InMed Pharmaceuticals is a global leader in the manufacturing and development of rare cannabinoids. Together with our subsidiary,
BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical
and health and wellness. We are a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering
new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit
www.inmedpharma.com.
About BayMedica
: BayMedica Inc.
is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry to develop an efficient, scalable,
and proprietary platform to produce high quality, rare cannabinoids for consumer applications and cannabinoid-derived new chemical entities
for pharmaceutical applications. For more information, visit www.baymedica.com.
Investor Contact:
Colin Clancy
Senior Director, Investor Relations
T: +1 604 416 0999
E
:
cclancy@inmedpharma.com
Edison Group:
Joe Green/Laine Yonker
T: +1.646.653.7030/+1.646.653.7035
E: jgreen@edisongroup.com / lyonker@edisongroup.com
Cautionary Note Regarding Forward-Looking Information:
This news release contains "forward-looking
information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning
of applicable securities laws. Forward-looking statements are frequently, but not always, identified by words such as "expects",
"anticipates", "believes", "intends", "potential", "possible", "would"
and similar expressions. Such statements, based as they are on current expectations of management, inherently involve numerous risks,
uncertainties and assumptions, known and unknown, many of which are beyond our control. Forward-looking information is based on management's
current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially
from those described in the forward-looking statements. Forward-looking information in this news release includes statements about: BayMedica's
plans for further product launches; the results and potential benefits of the combination of InMed and BayMedica's business models
and their future growth potential.
With respect to the forward-looking information
contained in this news release, InMed has made numerous assumptions regarding, among other things: the anticipated results and potential
of BayMedica's business and the combination of BayMedica's business with InMed's business occurring; continued economic
and market stability;
delivering new therapeutic alternatives to patients that may benefit from
cannabinoid-based pharmaceutical drugs; advancing IntegraSyn™ to commercial scale production; IntegraSyn™ being a commercially
viable solution for large-scale, pharmaceutical-grade GMP production of rare cannabinoids; and developing a pipeline of cannabinoid-based
pharmaceutical drug candidates
. While InMed considers these assumptions to be reasonable, these assumptions are inherently subject
to significant business, economic, competitive, market and social uncertainties and contingencies.
Additionally, there are known and unknown risk
factors which could cause InMed's actual results, performance or achievements to be materially different from any future results, performance
or achievements expressed or implied by the forward-looking information contained herein. Known risk factors include, among others: regulatory
filings may not be filed or approved on a timely basis, or at all. A more complete discussion of the risks and uncertainties facing InMed's
stand-alone business is disclosed in InMed's Annual Report on Form 10-K and other filings with the Security and Exchange Commission
on www.sec.gov and the most recent Annual Information Form and other continuous disclosure filed with Canadian securities regulatory authorities
on SEDAR at www.sedar.com.
All forward-looking information herein is qualified
in its entirety by this cautionary statement, and InMed disclaims any obligation to revise or update any such forward-looking information
or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results,
events or developments, except as required by law.

text: InMed Pharmaceuticals

text: BayMedica

text: InMed Pharmaceuticals Inc.

text: InMed

text: BayMedica Inc.

text: BayMedica

text: Eric A. Adams

text: InMed

text: BayMedica

text: InMed

text: BayMedica

text: BayMedica

text: InMed

text: InMed

text: BayMedica

text: InMed

text: BayMedica

text: InMed

text: InMed

text: Eric A. Adams

text: InMed

text: InMed Pharmaceuticals

text: BayMedica

text: BayMedica

text: BayMedica Inc.

text: BayMedica

text: InMed

text: BayMedica

text: InMed

text: BayMedica

text: BayMedica

text: InMed

text: InMed

text: InMed

text: InMed

text: InMed

text: InMed


text:
EX-99
6
alpp_ex99.htm
PRESS RELEASE
Alpine 4 Holdings (ALPP) Enters the Lithium / Graphene Battery Manufacturing Industry with its Latest Acquisition of ElecJet / Real Graphene and Plans to Bring its Battery Production to the United States
PHOENIX, Nov. 29, 2021 /PRNewswire/ -- Alpine 4 Holdings, Inc. (Nasdaq: ALPP), a leading operator and owner of small market businesses, announced today that it has acquired ElecJet / Real Graphene (ElecJet), an industry pioneer in Lithium / Graphene battery manufacturing and design. The two companies, Real Graphene and ElecJet, merged earlier this year, resulting in the combination of the graphene intellectual property of Real Graphene and the power system/charging hardware of ElecJet. The result of this merger was a symbiotic marriage of ground-breaking state-of-the-art battery and power system technology within a single company. ElecJet and Alpine 4 are also exploring plans with the State of Indiana to convert its South Bend, Indiana facility into a US battery production facility and bring graphene battery production to the United States.
https://realgrapheneusa.com
https://elecjet.com
Kent Wilson, CEO of Alpine 4, had this to say: "Earlier this year, Sam Gong, CEO of ElecJet, and I began working on a battery power solution that could meet the enormous power needs of our future US-2 drone. It was obvious that a pure lithium battery was not the answer for the US-2 design protocol, and different technologies would have to be implemented. Graphene became the obvious answer for us. Graphene is an amazing conductor of electricity and substantially reduces heat within lithium batteries during the charging cycle. That reduction in heat and resistance in graphene enhanced batteries allows for increased charging speeds and extended battery life.
The combined efforts of Alpine 4 and ElecJet culminated in two achievements. The first was recognizing that the business opportunities for ElecJet would be greatly enhanced as an Alpine 4 subsidiary. The second was that working together as one company, we could offer the electric vehicle (EV) market a new and compelling battery solution. Most EV manufacturers use pure lithium battery cells such as the 18650, 21700, and 4680. EV companies such as Rivian, Tesla, Lucid and others, utilize varying battery cells depending upon the power to energy density needs of the vehicle they are producing. ElecJet's graphene lithium battery offering will enhance all three primary battery cells currently used by EV manufacturers (18650, 21700, and 4680) in both power density and energy density. One key performance aspect of our graphene batteries is that they will be able to charge 5-8 times faster than the aforementioned lithium batteries can. Imagine charging your car from 0-80% at a DC rapid charging system in under 10 minutes compared to 30-45 minutes with just lithium batteries and subsequently not damage the battery cells within your vehicle like repeated DC charging can do. This will bring the feasibility of vehicles that use our graphene batteries in line with the time it takes to fill a conventional vehicle with gas. We feel this is the game-changer for the EV market as well as other various commercial applications".
Samuel Gong CEO of ElecJet had this to say: "People have been anxiously anticipating graphene for a decade, but it's mainly been contained in a lab. This has led to tons of hype and plenty of faux products and companies. But we're here to show that graphene batteries are not the future,
but the here and now. And while we are primarily a battery cell producer, we put our money where our mouth is by producing graphene battery power banks. We've created various sizes of direct-to-consumer graphene power banks that fully charge in just 17 minutes that are available for purchase on Amazon, our Shopify site and even our newly launched campaign on Indiegogo.
To put into perspective how impressive our resulting consumer products are, our latest power bank on Indiegogo is over three times the battery capacity of an iPhone 13 and will fully charge in just 27 minutes! We could charge even faster but USB C is capped at 100W. We've proven on a commercial scale that our graphene battery technology not only allows you to charge over 5 times faster than anything currently out there, but that it is a safe, mass producible, compact, cost-efficient, sustainable and consumer friendly product.
ElecJet/Real Graphene has the capability to bring graphene products from production phase to creating end-user consumer products. This wholistic, scalable capability is what has created our success. Kent has an amazing vision that our team is excited to be a part of, and his character upholds true core American values. Now that ElecJet/Real Graphene has joined the Alpine 4 family of companies, we can realize the next biggest evolution in the battery space in decades and put the US back into the driver's seat of this core technology".
ElecJet's newest power bank charger, the Apollo Ultra, was recently highlighted by Forbes Magazine and
digitaltrends.com
.
https://www.forbes.com/sites/marksparrow/2021/11/10/elecjet-apollo-ultra-power-bank-claims-to-be-the-fastest-charging-in-the-world/?sh=3f8b2637459e
https://www.digitaltrends.com/mobile/fast-charging-graphene-batteries-are-finally-here/
https://www.youtube.com/watch?v=dnE1nO6o-do
ElecJet will reside in the A4 Technologies, Inc., Portfolio as both a Driver and Facilitator from Alpine 4's DSF business model.
About Alpine 4 Holdings: Alpine 4 Holdings, Inc. (ALPP) is a NASDAQ traded conglomerate that acquires businesses that fit into its disruptive DSF business model of Drivers, Stabilizers, and Facilitators. At Alpine 4, we understand the nature of how technology and innovation can accentuate a business. Our focus is on how the adaptation of new technologies, even in brick-and-mortar businesses, can drive innovation. We also believe that our holdings should benefit synergistically from each other, have the ability to collaborate across varying industries, spawn new ideas, and create fertile ground for competitive advantages.
Four principles at the core of our business are Synergy. Innovation. Drive. Excellence. At Alpine 4, we believe synergistic innovation drives excellence. By anchoring these words to our combined experience and capabilities, we can aggressively pursue opportunities within and across vertical markets. We deliver solutions that not only drive industry standards, but also increase value for our shareholders.
Contact: Investor Relations
investorrelations@alpine4.com
www.alpine4.com
Forward-Looking Statements: Certain statements and information in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995. Statements that relate to our future operations, our ability to develop the technologies discussed above, and any financial performance based on the results of our merger with ElecJet, among others, as well as any statements that are not statements of historical facts constitute forward-looking statements. The information disclosed in this press release is made as of the date hereof and reflects Alpine 4 most current assessment of its historical financial performance. Actual financial results filed with the SEC may differ from those contained herein due to timing delays between the date of this release and confirmation of final audit results. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties, including the uncertainties surrounding the current market volatility, and other factors the Company identifies from time to time in its filings with the SEC. Although Alpine 4 believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Alpine 4 disclaims any intention or obligation to update the forward-looking statements for subsequent events.

text: Alpine 4 Holdings

text: ElecJet

text: Real Graphene

text: Alpine 4 Holdings, Inc.

text: ElecJet

text: Real Graphene

text: ElecJet

text: Real Graphene

text: ElecJet

text: Real Graphene

text: ElecJet

text: ElecJet

text: Kent Wilson

text: Sam Gong

text: ElecJet

text: ElecJet

text: ElecJet

text: ElecJet

text: Samuel Gong

text: ElecJet

text: ElecJet

text: ElecJet

text: Alpine 4 Holdings

text: Alpine 4 Holdings, Inc.

text: ElecJet


text:
EX-99.2
3
a07-22300_1ex99d2.htm
PRESS RELEASE, DATED AUGUST 20, 2007
Exhibit 99.2
PRESS RELEASE
Media Contact:
Terri Deuel
Internet Commerce Corporation
678-533-8003
Internet Commerce Corporation Announces Close
of EasyLink Services Corporation Acquisition and Name Change
Norcross,
Georgia - August 20, 2007
-
Internet Commerce Corporation ("ICC") (NasdaqCM: ICCA)
today
announced the completion of its acquisition of EasyLink Services Corporation ("EasyLink").
ICC announced a definitive agreement to acquire EasyLink on May 3, 2007.
Shareholder approval has been obtained, and all customary closing conditions
have now been satisfied.
The addition of
EasyLink's products and services now enables ICC to provide its customers
across the globe with a variety of messaging services, delivering a comprehensive
and unrivaled set of offerings to the marketplace. The Company's portfolio of
offerings will now include simple web-based fax delivery, sophisticated fax
hosting, tailored corporate e-mail messaging, EDI business-to-business
exchanges and specialized Telex protocol transmissions for marine and finance
industries.
With EasyLink, ICC
found the perfect strategic opportunity to further diversify its portfolio of
messaging services, increase its financial strength, and accelerate its growth.
Through this acquisition, ICC expects to generate more than $90 million in
revenue in fiscal year 2008 and demonstrate continued commitment to its
long-term "Growth with Profitability" strategy.
Simultaneous to
the completion of the EasyLink acquisition, ICC closed its Securities Purchase
Agreement with affiliates of York Capital Management ("York Capital"). York
Capital's financing for this transaction was announced in a press release on
May 3, 2007.
Also announced
today was a change to ICC's name and stock symbol. Internet Commerce
Corporation will now be known as EasyLink Services International Corporation
and trade under the symbol ESIC on the Nasdaq Capital Market.
As a result of ICC's
acquisition of EasyLink, EasyLink's common stock will no longer be publicly traded
and will convert into the right to receive $5.80 per share of common stock.
An investor call
will be scheduled in October to discuss ICC's fourth quarter and fiscal year
2007 results and the business plan for EasyLink Services International
Corporation.
About
EasyLink Services International Corporation
EasyLink Services
International Corporation (EasyLink) (NasdaqCM: ESIC), headquartered in
Norcross, GA, is uniquely positioned to deliver a variety of messaging services
that range from simple web-based fax delivery for small businesses to
sophisticated fax hosting, tailored corporate e-mail messaging, EDI
business-to-business exchanges, specialized Telex protocol transmissions for
marine and finance industries, and so much more. With more than $90 million in annual
revenue and over two decades of servicing customers around the globe, EasyLink has
established a proven track record for providing effective, reliable and secure
communications. For more information on EasyLink, visit www.easylink.com or
www.icc.net.
6025 The Corners Parkway, Suite 100
T
F
Norcross GA 30092
678.533.8000
770.246.4697
www.icc.net

text: Internet Commerce Corporation

text: Internet Commerce Corporation

text: EasyLink Services Corporation

text: Internet Commerce Corporation

text: ICC

text: EasyLink Services Corporation

text: EasyLink

text: ICC

text: EasyLink

text: EasyLink

text: ICC

text: EasyLink

text: ICC

text: ICC

text: EasyLink

text: ICC

text: ICC

text:
Internet Commerce
Corporation

text: ICC

text: EasyLink

text: EasyLink

text: ICC

text: EasyLink

text: EasyLink

text: EasyLink


text:
EX-99.1
2
a06-14379_1ex99d1.htm
EX-99
Exhibit 99.1
Company
Contact:
Brenda Morris
Chief Financial Officer
Zumiez Inc.
(425) 551-1564
Investor
Contact:
Integrated Corporate
Relations
Chad Jacobs/David
Griffith
(203)
682-8200
ZUMIEZ
INC. ANNOUNCES COMPLETION OF FAST FORWARD ACQUISITION
Acquisition
Expected to add $0.01 to $0.02 in EPS in 2006 and $0.08 to $0.09 in EPS in 2007
Everett, WA - June 26, 2006 -
Zumiez Inc. (NASDAQ: ZUMZ) announced today that it has completed its previously
announced acquisition of Fast Forward, a leading action sports retailer with 19
stores and a web store. Of the 19
stores, 16 are in Texas, with one store in California and two stores in
Oklahoma. The acquisition was funded
from cash on hand.
Over the course of the next
18 months, the Fast Forward stores will be converted to the Zumiez
nameplate. These additional stores will
be incremental to the planned 42 stores in 2006. The company continues to expect the
acquisition to add $0.01 to $0.02 to earnings per share in 2006 and to be
accretive to earnings per share by approximately $0.08 to $0.09 in fiscal 2007.
Rick Brooks, President and
Chief Executive Officer of Zumiez Inc., stated, "We have already started
working with the Fast Forward team and are excited about the combination of our
cultures and how well we are aligned. We
look forward to our continued expansion into Texas and other markets with our
unique action sports retail concept".
Mr. Brooks concluded, "I want to thank all of the Fast Forward team and
our Zumiez integration team for all of their hard work in helping us complete
the Fast Forward acquisition".
About
Zumiez Inc.
Zumiez is a leading specialty retailer of
action sports related apparel, footwear, equipment and accessories. Our stores cater to young men and women
between ages 12-24, focusing on skateboarding, surfing, snowboarding, motocross
and BMX. As of June 23, 2006 we operate
189 stores, which are primarily located in shopping malls and our web site
address is www.zumiez.com.
Safe
Harbor Statement
Certain
statements in this press release and oral statements relating thereto made from
time to time by representatives of the company may constitute forward-looking
statements for purposes of the safe harbor provisions under the Private
Securities Litigation Reform Act of 1995.
These statements include, without limitation, predictions and guidance
relating to the company's future financial performance, integration of acquired
businesses, growing customer demand for our products and new store openings. In
some cases, you can identify forward-looking statements by terminology such as,
"may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts,"
"potential", "continue", or the negative of these terms or other comparable
terminology. These forward-looking statements
are based on management's current expectations but they involve a number of
risks and uncertainties. Actual results
and the timing of events could differ materially from those anticipated in the
forward-looking statements as a result of risks and uncertainties, which
include, without limitation, those described under the heading Risk Factors in
the company's quarterly report on Form 10-Q for the quarterly period ended
April 29, 2006 as filed with the Securities and Exchange Commission and
available at www.sec.gov. You are urged
to consider these factors carefully in evaluating the forward-looking
statements herein and are cautioned not to place undue reliance on such
forward-looking statements, which are qualified in their entirety by this
cautionary statement. The
forward-looking statements speak only as of the date on which they are made and
the company undertakes no obligation to publicly update such forward-looking
statements to reflect subsequent events or circumstances.

text: Brenda Morris

text: Zumiez Inc.

text:
ZUMIEZ
INC.

text: FAST FORWARD

text: Zumiez Inc.

text: Fast Forward

text: Fast Forward

text: Rick Brooks

text: Zumiez Inc.

text: Fast Forward

text: Fast Forward

text: Fast Forward

text: Zumiez Inc.


text:
EX-99.2
3
s000823x3_ex99-2.htm
EXHIBIT 99.2
EXHIBIT 99.2
Uroplasty
and Vision Sciences Complete Merger
Merged Company is now Cogentix Medical, Inc.
Combination
Creates New Medical Device Company Positioned for Growth
Cogentix
shares will begin trading under symbol CGNT on April 1, 2015
MINNEAPOLIS,
MN & ORANGEBURG, NY, March 31, 2015
-- Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ:
VSCI) today announced the completion of their merger. The merger agreement was originally announced in December 2014, and completion
of the all-stock combination creates a new medical device company named Cogentix Medical, Inc. Beginning on April 1, 2015, Cogentix
Medical, Inc. will trade on the NASDAQ under the symbol CGNT. Cogentix Medical will have its U.S. headquarters in Minnetonka, MN,
where Uroplasty's current headquarters is located.
Cogentix Medical will initially focus on
leveraging its innovative product offerings in urology under the leadership of the Uroplasty management team, with Rob Kill serving
as President and CEO. "The completion of our merger with Vision-Sciences and the creation of Cogentix Medical marks another
milestone on our path to accelerating revenue growth and broadening our product offerings to physicians", said Rob Kill, President
and CEO of Cogentix. "We remain highly confident in the benefits of this merger combination, our ability to leverage our distribution
platform and the future growth prospects for Cogentix Medical. We look forward to working with the members of the former Vision-Sciences
team to complete our integration plans and realize the significant synergies the merger has created".
Cogentix Medical is expected to generate
revenue of approximately $50 million for the fiscal year beginning April 1, 2015, as well as realize cost synergies of approximately
$3 million.
Uroplasty's financial advisor was Piper Jaffray &
Co. and its legal advisor was Oppenheimer Wolff & Donnelly LLP. Vision-Sciences' financial advisor was Leerink Partners
LLC and its legal advisor was Royer Cooper Cohen Braunfeld LLC.
About Cogentix
Cogentix Medical, Inc., headquartered in
Minnetonka, Minnesota, with operations in New York, The Netherlands and the United Kingdom, is a global medical device company.
We design, develop, manufacture and market products for flexible endoscopy with our unique product lines featuring a streamlined
visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, providing users with
efficient and cost effective endoscope turnover while enhancing patient safety. We also commercialize the Urgent® PC Neuromodulation
System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive
bladder (OAB). OAB is a chronic condition that affects approximately 42 million U.S. adults. The symptoms include urinary urgency,
frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult
female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on Cogentix and ours products,
please visit us at
www.cogentixmedical.com.
.
For Further Information:
Cogentix Medical, Inc.
Brett Reynolds, SVP and CFO
952-426-6152
EVC Group
Doug Sherk/Brian Moore (Investors)
415-652-9100/310-579-6199
Janine McCargo (Media)
646-688-0425
Cautionary Statements Related to Forward-Looking Statements
This press release includes forward-looking statements. These forward-looking
statements generally can be identified by the use of words such as "anticipate", "expect", "plan,"
"could", "may", "will", "believe", "estimate", "forecast,"
"goal", "project", and other words of similar meaning. Forward-looking statements in this press
release include, but are not limited to, statements about the benefits of the merger transaction; expected revenue growth rates;
and the company's plans, objectives, expectations and intentions with respect to future operations, products and services.
Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among
others, the risk that ongoing shareholder litigation in connection with the merger transaction may result in significant costs
of defense, indemnification and liability; other business effects, including the effects of industry, economic or political conditions
outside of either company's control; the failure to realize synergies and cost-savings from the merger transaction or delay
in realization thereof; the businesses of Uroplasty and Vision-Sciences may not be combined successfully, or such combination
may take longer, be more difficult, time-consuming or costly to accomplish than expected; operating costs and business disruption
following completion of the transaction, including adverse effects on employee retention and on the combined company's respective
business relationships with third parties; transaction costs; actual or contingent liabilities; the adequacy of the combined company's
capital resources; and the risks identified under the heading "Risk Factors"
in
the joint proxy statement/prospectus filed with the Securities and Exchange Commission ("SEC") on February 23, 2015,
in Uroplasty's Annual Report on Form 10-K, for the fiscal year ended March 31, 2014, filed with the SEC on June 9, 2014,
and Vision-Sciences' Annual Report on Form 10-K for the fiscal year ended March 31, 2014, filed with the SEC on May 30,
2014, as well as Uroplasty's and Vision-Sciences' subsequent Quarterly Reports on Form 10-Q and other information
filed by each company with the SEC. Cogentix cautions investors not to place considerable reliance on the forward-looking statements
contained in this press release. You are encouraged to read Uroplasty's and Cogentix's filings with the SEC,
available at
www.sec.gov
, for a discussion of these and other risks and uncertainties. The forward-looking statements in
this press release speak only as of the date of this release, and Cogentix undertake no obligation to update or revise any of
these statements. Cogentix businesses are subject to substantial risks and uncertainties, including those referenced above.
Investors, potential investors, and others should give careful consideration to these risks and uncertainties.

text: Uroplasty

text: Vision Sciences

text: Uroplasty

text: Vision-Sciences

text: Uroplasty

text: Uroplasty

text: Rob Kill

text: Vision-Sciences

text: Rob Kill

text: Vision-Sciences

text: Uroplasty

text:
Piper Jaffray &
Co.

text: Oppenheimer Wolff & Donnelly LLP

text: Vision-Sciences

text:
Leerink Partners
LLC

text: Royer Cooper Cohen Braunfeld LLC

text: Uroplasty

text: Vision-Sciences

text: Uroplasty

text: Vision-Sciences

text: Uroplasty

text: Vision-Sciences

text: Uroplasty


text:
EX-99.1
2
elsegundopressrelease.htm
EL SEGUNDO PRESS RELEASE
elsegundopressrelease.htm
News
Release
For
Immediate
Release For
Further Information, Contact:
March
19,
2008
George
Lancaster, Hines
713/966-7676
George_lancaster@hines.com
HINES
REIT ACQUIRES RAYTHEON AND DIRECTV BUILDINGS
(LOS
ANGELES, CA) - The Los Angeles office of Hines, the international real estate
firm, announced today that Hines REIT has acquired the Raytheon and DIRECTV
buildings, a two-building office complex in the South Bay submarket in El
Segundo, CA, from Newkirk Segair L.P. The seller was represented by Eastdil
Secured in the transaction. Hines is the sponsor of Hines REIT, and is
responsible for the acquisition, management and leasing of its
assets.
The
complex is located along Imperial Highway Corridor near the junction of the
405
and 105 freeways in close proximity to the Los Angeles International
Airport. Situated on a 6.14-acre site, the complex comprises 550,579
rentable square feet distributed in two 11-story Class A office buildings,
including two levels of office space on top of the 10-story parking garage.
The
complex was completed in 1976 and features a distinctive mirrored glass façade,
state-of-the-art building systems and a landscaped courtyard.
At
100
percent leased, the property is anchored by two tenants, Raytheon's Space and
Airborne Systems, one of the top U.S. defense contractors; and DIRECTV Group,
Inc., the largest U.S.-based direct broadcast satellite (DBS)
provider.
"We
believe that the acquisition of the Raytheon and DIRECTV properties will further
enhance the Hines REIT portfolio with the buildings' superior accessibility,
long-term tenancy and Class A office space, which is well suited for the tenant
base", said Charles Hazen, president of Hines REIT.
"Hines
has acquired more than 2.6 million square feet valued at more than $1 billion
in
Los Angeles County within the past 18 months, reaffirming our strong belief
in
the local real estate markets", said Hines Senior Vice President Colin
Shepherd.
Hines
REIT is a Houston-based public real estate investment trust sponsored by
Hines. Hines REIT commenced operations in November 2004 and primarily
invests in institutional-quality office properties located in the United States.
Including this acquisition, Hines REIT currently owns interests in 43
properties, two of which are located outside of the United
States. For additional information about Hines REIT, please see
www.hinesreit.com.
Hines
is
a fully integrated real estate investment and management firm that has been
investing in real estate and providing acquisition, development, financing,
property management, leasing and disposition services for over 50
years. With offices in 69 U.S. cities and 15 foreign countries, and
controlled assets valued at approximately $19.9 billion, Hines is one of the
largest real estate organizations in the world. Access
www.hines.com
for more information on Hines.
Statements
in this news release, including but not limited to those relating to intentions,
beliefs, expectations, projections, plans or predictions, including
effects and results of the acquisition and other statements that are not
historical facts are forward looking statements that are based on current
expectations and assumptions that may prove incorrect or
inaccurate. Important factors that could cause actual results to
differ materially from those in the forward looking statements include risks
associated with property acquisitions, changes in general economic and real
estate market conditions, interest rate fluctuations, competition, dependence
on
tenants' financial condition, dependence on Hines and other risks described in
the "Risk Factors" sections of Hines REIT's Registration Statement on Form S-11,
its Annual Report on Form 10-K, and its other filings with the Securities and
Exchange Commission.
-30-

text:
HINES
REIT

text: RAYTHEON

text: DIRECTV BUILDINGS

text: Hines REIT

text: Raytheon

text:
DIRECTV
buildings

text: Newkirk Segair L.P.

text:
Eastdil
Secured

text: Hines REIT

text: Raytheon

text: Raytheon

text: Hines REIT

text: Charles Hazen

text: Hines REIT

text:
Hines
REIT

text: Hines REIT

text: Hines REIT

text: Hines REIT

text: Hines REIT


text:
EX-99
2
americaninternation.htm
PRESS RELEASE DATED JANUARY 6, 2005
American International Petroleum Corporation and American International Refinery, Inc. Announce Completion of Sale of Lake Charles Refinery
HOUSTON, TX -- 01/06/2005 -- American International Petroleum Corporation
("AIPC") (OTC: AIPN) and American International Refinery, Inc. ("AIRI"), a
wholly owned subsidiary of AIPC, announced today that on December 31, 2004,
AIRI consummated the sale of its Lake Charles Refinery and all associated
real and personal property to Pelican Refining Company L.L.C. for $9
million in cash. Pelican Refining Company L.L.C. is owned by NuCoastal
Refining and Marketing Company and BayOil (USA) Limited. The sale was
conducted pursuant to an auction process under the supervision of the
United States Bankruptcy Court for the Western District of Louisiana, Lake
Charles Division. On December 9, 2004, the Bankruptcy Court approved the
sale, subject to certain closing terms and conditions, including closing of
the sale by the end of 2004. AIRI used the proceeds from the sale
transaction to pay certain Bankruptcy Court approved obligations, including
payment of its bankruptcy expenses, real property taxes, environmental
fees, and payment of approximately $4.6 million to its secured lender,
Halifax Fund LP, pursuant to a settlement agreement among AIRI, AIPC and
Halifax approved by the Bankruptcy Court. This sale and settlement fully
satisfies all obligations of AIRI and AIPC to Halifax. Neither AIPC nor
AIRI expect proceeds from the sale to be available for distribution to
their common stockholders.
American International Petroleum Corporation is a petroleum company that,
through certain subsidiaries, is involved in oil and gas exploration and
development in Kazakhstan.
All statements, other than statements of historical fact, including
statements regarding AIPC's current expectations regarding the use of
proceeds from the sale transaction, included in this press release, are
forward-looking statements, including, but not limited to, statements
identified by the words, "expect", "will" and similar expressions and
statements regarding our legal position, plans and objectives. These
statements reflect our current views with respect to future events, based
on what we believe are reasonable assumptions. Certain factors could cause
actual results to differ materially from results anticipated in the
forward-looking statements. These factors include, but are not limited to,
AIPC's bankruptcy proceeding.
Contact:
Michael Dodge
Corporate Communications
732.741.5749

text: American International Refinery, Inc.

text: Lake Charles Refinery

text: American International Refinery, Inc.

text: Lake Charles Refinery

text: Pelican Refining Company L.L.C.

text: Pelican Refining Company L.L.C.


text:
EX-99.1
3
file002.htm
PRESS RELEASE
Cyclacel Pharmaceuticals, Inc.
CYCLACEL
PHARMACEUTICALS ESTABLISHED WITH COMPLETION OF CYCLACEL GROUP PLC
AND
XCYTE THERAPIES TRANSACTIONS
SHORT HILLS,
NJ
March 28, 2006 - Cyclacel Group plc announced today that it
has completed the previously announced transactions with Xcyte Therapies, Inc.
In connection with the closing, the previously announced one-for-ten reverse
stock split was completed before the opening of the market on March 27, 2006
and the combined company was renamed Cyclacel Pharmaceuticals, Inc. (Cyclacel).
Cyclacel is focused on the discovery and development of small molecule cell
cycle inhibitors for the treatment of cancer and other serious diseases.
Currently the company has two drugs, seliciclib (CYC202) and sapacitabine
(CYC682), in clinical trials for the treatment of cancer, a third compound in
late preclinical development, a large pipeline of development candidates, and a
productive drug discovery engine.
The new company has
approximately 9.7 million common shares following the reverse stock split and
approximately 2.0 million preferred shares outstanding which would be
equivalent to 0.9 million shares of common stock if converted. Cyclacel has
approximately $30 million in cash and marketable securities.
Cyclacel common stock
is expected to begin trading on the Nasdaq National Market under the ticker
symbol "CYCC" on March 28. Cyclacel preferred stock is expected to
begin trading on the Nasdaq Capital Market under the ticker symbol,
"CYCCP".
"We believe that
cell cycle inhibition represents one of the most promising, mechanism-targeted
approaches for the treatment of cancer, as well as other serious proliferative
diseases", said Spiro Rombotis, President and Chief Executive Officer.
"Our scientists at Cyclacel have built a strong position in the discovery
and development of complementary product candidates aimed at several cell cycle
phases and targets. We look forward to expanding our clinical programs at
hospitals in the U.S. and elsewhere and advancing our development
pipeline".
The company's
lead cancer programs include:
.
Seliciclib (CYC202), a Cyclin Dependent Kinase (CDK) inhibitor in
Phase II clinical trials for the treatment of non-small cell lung cancer.
Cyclacel expects to commence shortly a randomized, double-blinded Phase IIb
clinical trial comparing seliciclib to placebo in patients with non-small cell
lung cancer;
.
Sapacitabine (CYC682), a nucleoside analog in Phase I trials. Cyclacel
expects to commence shortly a Phase Ib clinical trial of sapacitabine in
patients with advanced hematological cancers;
.
CYC116, an Aurora kinase inhibitor in IND-directed preclinical
development. Cyclacel expects to file an IND in the second half of
2006.
In addition, the
company has eight early stage programs that target important cell cycle
mechanisms for the treatment of cancer, Type 2 diabetes, inflammatory kidney
diseases and viral infections.
Cyclacel's
strategy is to build a significant franchise in oncology, both through organic
growth and through selective partnerships. Cyclacel's research and
development alliance partners include Altana, Genzyme, and Sankyo. As a private
company Cyclacel raised approximately $114 million from a large number of
global institutional investors.
Transaction
Details
The transactions were
structured as an acquisition by Xcyte of all of the outstanding share capital
of Cyclacel Limited from Cyclacel Group in exchange for the issuance of shares
of Xcyte common stock. Xcyte shareholders approved the transactions on March
16, 2006. In connection with the transactions Xcyte also sold
150 JFK
Parkway, Suite 100, Short Hills, New Jersey 07078, USA Tel +1 (973)
847 5955 Fax +1 (866) 271 3466
Dundee
Technopole, James Lindsay Place, Dundee, DD1 5JJ, UK Tel +44 1382 206 062
Fax +44 1382 206 067
www.cyclacel.com - info@cyclacel.com
2
certain discontinued
technology and assets for $5 million to Invitrogen Corporation on March 24,
2006 and effected a one-for-ten reverse stock split on March 27, 2006.
Upon completion of
the transactions, Cyclacel Limited became a wholly owned subsidiary of Xcyte
and Xcyte was renamed Cyclacel Pharmaceuticals, Inc. Following the issuance by
Xcyte of shares of its common stock to Cyclacel Group plc in exchange for all
of the outstanding share capital of Cyclacel Limited, Cyclacel Group plc
distributed the Xcyte stock received through a members' voluntary
liquidation of Cyclacel Group plc under English law. As a condition of the
liquidation certain former Cyclacel Group plc shareholders agreed to certain
restrictions with regard to transferring their Cyclacel shares for a period of
six (6) months from today. As a result of the transaction former Cyclacel Group
plc shareholders own approximately 80 percent and former Xcyte shareholders
approximately 20 percent of the common stock of Cyclacel
Pharmaceuticals.
About Cyclacel
Pharmaceuticals, Inc.
Cyclacel is a
clinical-stage biopharmaceutical company dedicated to the discovery,
development and commercialization of novel, mechanism-targeted drugs to treat
human cancers and other serious disorders. The company is currently evaluating
seliciclib (CYC202), an orally-available cyclin dependent kinase inhibitor, in
Phase II clinical trials for the treatment of lung cancer. Sapacitabine
(CYC682) is an orally-available, cell cycle modulating nucleoside analog in
Phase I clinical trials for the treatment of cancer. CYC116 is an
orally-available, Aurora kinase inhibitor in IND-directed preclinical
development. Several additional programs are at an earlier stage.
Note: The Cyclacel
logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc.
Risk Factors
This news release
contains certain forward-looking statements that involve risks and
uncertainties that could cause actual results to be materially different from
historical results or from any future results expressed or implied by such
forward-looking statements. Such forward-looking statements include statements
regarding, among other things, the efficacy, safety, and intended utilization
of Cyclacel's product candidates, the conduct and results of future
clinical trials, plans regarding regulatory filings, future research and
clinical trials and plans regarding partnering activities. Factors that may
cause actual results to differ materially include the risk that product
candidates that appeared promising in early research and clinical trials do not
demonstrate safety and/or efficacy in larger-scale or later clinical trials,
the risk that Cyclacel will not obtain approval to market its products, the
risks associated with reliance on outside financing to meet capital
requirements, and the risks associated with reliance on collaborative partners
for further clinical trials, development and commercialization of product
candidates. You are urged to consider statements that include the words
"may", "will", "would", "could,"
"should", "believes", "estimates,"
"projects", "potential", "expects,"
"plans", "anticipates", "intends,"
"continues", "forecast", "designed,"
"goal", or the negative of those words or other comparable words to
be uncertain and forward-looking. These factors and others are more fully
discussed under "Risk Factors" in the registration statement on Form
S-4 (File No. 333-131225) filed with the SEC in connection with the
transactions.
Contacts for
Cyclacel:
For
Investors:
TS Communications Group, LLC (914) 921-5900
Tara
Spiess
For Media:
Feinstein Kean Healthcare: (617) 577-8110
Robert Gottlieb / Courtney
Harris

text: CYCLACEL GROUP PLC

text: Cyclacel Group plc

text: Xcyte Therapies, Inc

text: Spiro Rombotis

text: Cyclacel Group plc

text: Cyclacel Group plc

text: Cyclacel Group plc

text: Cyclacel Group plc

text:
Cyclacel Group
plc


text:
EX-99
2
ex99-1.htm
PRESS RELEASE 2_14_05
Exhibit
99.1
NEWS
RELEASE
Monday,
February 14, 2005 8:00 p.m. ET
FLOTEK
INDUSTRIES, INC.
7030 Empire
Central Drive, Houston, Texas 77040
TRADING
SYMBOL: OTCBB:FLTK
For more
information contact: Rosalie Melia
Tel:
713-849-9911 Fax:
713-466-8386
rmelia@flotekind.com
FLOTEK COMPLETES $13 MILLION CREDIT FACILITY AND ACQUISITION OF SPIDLE SALES AND SERVICES, INC.
HOUSTON, Feb. 14, 2005 -Flotek Industries, Inc. (FLTK.OB), announced it had completed the previously announced acquisition of Spidle
Sales and Services, Inc., ("Spidle"). The acquisition was financed with a new $13 million senior credit facility funded through
Wells Fargo Commercial Banking in Houston. The new facility is comprised of an $8 million term loan and a $5 million revolving
credit facility. Initial borrowings under this facility were used to finance the acquisition of Spidle and repay Flotek's existing
senior credit facility. In addition to significantly increasing the Company's working capital availability, Flotek's senior
borrowing rates were reduced approximately 300 basis points as a result of the new financing.
The purchase consideration for Spidle totaled $6.1 million cash, $1.275 million seller financing and 129,271 shares of common stock.
Spidle will be merged with Turbeco into Flotek's drilling products segment. Spidle (www.spidle.com) is one of the premier downhole
tool companies with rental, sales and manufacturing operations throughout the Rocky Mountains. Spidle serves both the domestic and
international downhole tool markets with a customer base extending into Canada, Mexico, South America, Europe, Asia and Africa.
Spidle operates in the energy, mining, water well and industrial drilling sectors.
"The new credit facility is a significant achievement, which will further strengthen our capital structure and lower our interest
expense. The additional liquidity will enable our ongoing expansion in existing markets, and support our efforts to pursue
opportunities in new markets", stated Jerry D. Dumas, Sr., Chairman and Chief Executive Officer of Flotek.
More detail will be available in the
Company's 8-K AND 10-K to be filed with the SEC. For product information and additional
information on the Company, please visit Flotek's web site at
http://www.flotekind.com
Flotek is a publicly traded company
involved in the manufacturing and marketing of innovative specialty chemicals, downhole
drilling and production equipment, and management of automated bulk material handling,
loading and blending facilities. It serves major and independent companies in the domestic
and international oilfield service industry.
Statements made in this press
release, including those relating to the positive direction of the Company, increased
revenue base, are forward-looking and are made pursuant to the safe harbor provisions of
the Securities Litigation Reform Act of 1995. Such statements involve risks and
uncertainties, which may cause results to differ materially from those set forth in these
statements. Other factors identified in the Company's filings with the Securities and
Exchange Commission could also affect the forward-looking statements contained in this
press release.

text:
FLOTEK
INDUSTRIES, INC.

text: FLOTEK

text: SPIDLE SALES AND SERVICES, INC.

text: Flotek Industries, Inc.

text:
Spidle
Sales and Services, Inc.

text: Spidle

text: Spidle

text: Flotek

text: Flotek

text: Spidle

text: Spidle

text: Flotek

text: Spidle

text: Spidle

text: Spidle

text: Flotek

text: Flotek

text: Flotek


text:
EX-99.1
6
a4944766ex991.txt
EXHIBIT 99.1
Exhibit 99.1
Metromedia International Group Inc. Announces
Consummation of PeterStar Sale and Redemption of Senior Notes
CHARLOTTE, N.C.--(BUSINESS WIRE)--Aug. 1, 2005--Metromedia
International Group, Inc. (the "Company") currently traded as: (PINK
SHEETS: MTRM) - Common Stock and (PINK SHEETS: MTRMP) - Preferred
Stock, the owner of interests in communications and media businesses
in the country of Georgia, announced that the Company has today
completed the previously disclosed sale of its entire interest in ZAO
PeterStar (the "PeterStar Sale"). The cash purchase price of $215
million was today deposited in the Company's account and all remaining
formalities connected with transfer of the Company's interest in ZAO
PeterStar to the buyer were satisfactorily concluded.
The Company also announced that it has sent a notice of redemption
of all of the Company's outstanding 10 1/2% Senior Notes due 2007 (the
"Senior Notes") to the trustee for the Senior Notes. The aggregate
redemption price of the Senior Notes, including accrued interest, is
approximately $157.7 million. The Company anticipates that the
redemption will be completed on August 8, 2005 and will be funded out
of a portion of the proceeds from the PeterStar Sale, which will be
placed on deposit with the trustee later this week.
About Metromedia International Group
Through its wholly owned subsidiaries, the Company owns interests
in communications and media businesses in the country of Georgia.
Since the first quarter of 2003, the Company has focused its principal
attentions on the continued development of its core telephony
businesses, and has substantially completed a program of gradual
divestiture of its non-core cable television and radio broadcast
businesses. The Company's core telephony businesses includes Magticom,
Ltd., the leading mobile telephony operator in Tbilisi, Georgia, and
Telecom Georgia, a well-positioned Georgian long distance telephony
operator.
This news release contains certain forward-looking statements that
involve risks and uncertainties, including in particular those
regarding the timing of completing the Company's redemption of the
Senior Notes. Various other factors beyond the Company's control could
cause or contribute to such risks and uncertainties. This also
includes such factors as are described from time to time in the SEC
reports filed by the Company, including the Current Annual Report on
Form 10-K for the year ended December 31, 2003, the Company's Form
10-Q for the fiscal quarters ended March 31, 2004, June 30, 2004 and
September 30, 2004 and its most recently filed Form 8-K reports (dated
October 19, 2004, November 4, 2004, November 16, 2004, November 22,
2004 and December 9, 2004, January 6, 2005, February 9, 2005, February
17, 2005, March 9, 2005, March 23, 2005, April 19, 2005, April 20,
2005, June 7, 2005, June 17, 2005, July 12, 2005, July 18, 2005, July
25, 2005 and July 28, 2005). The Company is not under, and expressly
disclaims any, obligation to update the information in this news
release for any future events.
CONTACT: Metromedia International Group, Inc.
Ernie Pyle, 704-321-7380
investorrelations@mmgroup.com

text: Metromedia International Group

text:
Metromedia
International Group

text:
ZAO
PeterStar

text:
ZAO
PeterStar

text: Metromedia International Group

text: Metromedia International Group


text:
EX-99.1
2
rrd199178_23643.htm
PRESS RELEASE DATED MARCH 5, 2008
Exhibit 99.1
Hungarian Telephone and Cable Corp.
1201 Third Avenue, Suite 3400 Puskas Tivadar u. 8-10
Seattle, WA 98101-3034 - U.S.A. H-2040 Budaors, Hungary
Phone (206) 654-0204 - Fax (206) 652-2911 Phone (361) 801-1500 - Fax (361) 801-1501
FOR: HUNGARIAN TELEPHONE AND CABLE CORP.
COMPANY
CONTACT: Robert Bowker
Chief Financial Officer
Hungary: (011) 361-801-1500
U.S.: (206) 654-0204
FOR IMMEDIATE RELEASE
HUNGARIAN TELEPHONE AND CABLE CORP. ANNOUNCES COMPLETION OF MEMOREX ACQUISITION
SEATTLE, Wash., March 5, 2008 - Hungarian Telephone and Cable Corp. (AMEX:HTC) announced today that it has completed the purchase of Austrian-based Memorex Telex Communications AG ("Memorex"). The purchase price for Memorex was EUR 30.1 million
(approximately $45.8 million) to the selling shareholders of Memorex for their 95.7% equity interest plus the assumption of Memorex's debt. HTCC refinanced a significant portion of Memorex's debt at closing. HTCC funded the Memorex Acquisition and the refinancing of the assumed Memorex debt with a subordinated bridge loan facility arranged by Merrill Lynch and BNP Paribas. HTCC intends to subsequently replace the bridge loan facility with longer term financing. HTCC also intends to buy out the remaining minority shareholders in Memorex.
Memorex is one of the leading alternative telecommunications providers in the Central and Eastern European region providing wholesale data and capacity services to leading global telecommunications providers and Internet companies. Memorex provides services between 14 countries in the region including Austria, Bulgaria, the Czech Republic, Italy, Romania, Slovakia, Turkey, and Ukraine. Memorex operates over 12,500 route km of fiber optic cable in the region which enables it to provide high quality wholesale services to its blue-chip customer base. It has about 100 employees and has invested approximately EUR 54 million (approximately $82.1 million) in its network over the last two years.
Commenting on the completion of the Memorex acquisition, Hungarian Telephone and Cable Corp.'s President and Chief Executive Officer, Martin Lea said, "We are very pleased to announce the completion of the Memorex acquisition, which further develops our position in the Wholesale market in the Central and Eastern European region, particularly in Turkey. We are now undoubtedly the leading provider of wholesale data and capacity services in the Central and Eastern European market. Memorex has grown its business in the last few years and we expect to be able to further expand our business in the region. We expect broadband Internet penetration to continue to grow in the region along with the data transmission business given that the Central and South-Eastern European countries are growing faster in terms of GDP compared to the Euro-zone countries. Our combined network will enable us to take advantage of this growth in the region since we are able to offer our wholesale customer base a one-stop high quality solution for the entire region. Our combined network covers the whole region including hard-to-reach countries like Macedonia, Albania and Moldova. We also expect to benefit from cost synergies with expected annual operating cost savings of EUR 3 million (approximately $4.6 million), which we should realize within the first two years".
ABOUT HUNGARIAN TELEPHONE AND CABLE CORP.
Hungarian Telephone and Cable Corp., operating under the Invitel brand name, is the number one alternative and the second-largest fixed line telecommunications and broadband Internet Services Provider in the Republic of Hungary with more than 1 million customers in Hungary. In addition to delivering voice, data and Internet services in Hungary, it is also a major player in the Central and Eastern European wholesale telecommunications market.
###

text: Hungarian Telephone

text: Cable Corp.

text: HUNGARIAN TELEPHONE

text: CABLE CORP.

text: Robert Bowker

text: HUNGARIAN TELEPHONE

text: CABLE CORP.

text: MEMOREX

text: Hungarian Telephone

text: Cable Corp.

text: Memorex Telex Communications AG

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Memorex

text: Hungarian Telephone

text: Cable Corp.

text: Memorex

text: Memorex

text: HUNGARIAN TELEPHONE

text: CABLE CORP.

text: Hungarian Telephone

text: Cable Corp.


text:
EX-99
22
ex991.htm
PRESS RELEASE
Exhibit 99.1
CornerWorld Completes Acquisition of Woodland Wireless
DALLAS, Feb. 24 /PRNewswire-FirstCall/ -- CornerWorld Corporation (OTC Bulletin Board: CWRL) today announced the completion of its approximately $12.2 million USD acquisition of Woodland Wireless Solutions. The acquisition, announced October 28, 2008, represents all holdings of Woodland Wireless including the patented shortcode roaming application, Visitatel, West Michigan Co-Location Services, T2 TV, T2 Communications (www.t2comm.net) and S Squared.
CornerWorld Corporation, a media company, is leveraging its proprietary lead generation engine to deliver qualified prospective customer leads to Fortune 1000 advertisers using online channels, social networking properties, CornerWorld-owned and partner representative content websites. Using Woodland's patented technology, CornerWorld will extend its lead generation capability to include the millions of mobile customer impressions taking place on Woodland's owned services.
"We are confident that mobile computing is the consumers bridge between real-world and online worlds", said Scott Beck, CEO, CornerWorld. "We are thrilled to begin incorporating Woodland's mobile platform and operational experience with more than 50 wireless carriers in the United States, Canada and the Caribbean, to create next-generation offerings that will unite buyers and sellers by expanding the application of Woodlands cellular roaming patent".
"Our carrier customers who provide more than 65 percent of U.S. consumers with mobile devices will continue to have the mission-critical roaming service they expect", said Ned Timmer, CEO, Woodland Wireless. "We now have the resources to expand services that will benefit carriers and enhance the mobile computing investment for consumers".
About Woodland Wireless Group
Woodland is an application service provider to the cellular industry serving 50 cellular providers in North America. The core service provided is a patented roaming services application, that provides a seamless means for wireless subscribers to reach their home provider's customer service call center while roaming on another provider's network. Visitatel holds an FCC 214 license as a wholesale long distance service provider to the carrier community and large commercial users of transport minutes. West Michigan Co-Location Services is an equipment leasing company for telecommunications companies. T2 provides telephone, Internet access and Internet Protocol television (IPTV) service, "the Triple Play", as well as data center services and collocation to residential and business customers in Holland, Michigan. For more information, visit (www.t2comm.net).
About CornerWorld Corporation
CornerWorld is a media corporation which operates several fast-growing businesses in verticals that serve brand and direct marketers seeking to produce measurable results for each advertising dollar spent. Cornerworld.com is a free, groundbreaking business management and social networking platform that empowers independent content creators to share and profit from their skills. For more information, visit (www.cornerworld.com).
Enversa Companies, a subsidiary of CornerWorld and a leading marketing communications provider, offers a full menu of services for brand and direct response customer acquisition campaigns, including media buying and planning for online and mobile media. It provides customer relationship marketing and interactive services, as well as customer data collection and analysis tools used for planning and targeting client marketing efforts across a network of partner, representative and owned content sites, including CornerWorld.com. Enversa operates several ad networks and a proprietary RFP technology that highlights promotional offers from a variety of corporate clients. The company uses an established media auction technology that expands inventory and effectively enables media properties to compete against each other, empowering advertisers to extend their marketing budgets beyond typical marketplace levels
through open market competition. For more information, visit (www.enversacompanies.com)
Safe Harbor
This press release contains forward-looking statements that involve a number of risks and uncertainties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements can be identified by the words, "expects", "continues", "projects", "hopes", "believes", "could", and other similar words. Forward-looking statements are based on management's beliefs, as well as assumptions made by, and information currently available to, management. Because such statements are based on expectations and are not statements of fact, actual events and results may differ materially from those projected. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or
achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

text: CornerWorld

text: Woodland Wireless

text: CornerWorld Corporation

text: Woodland Wireless Solutions

text: Woodland Wireless

text: CornerWorld Corporation

text: CornerWorld

text: Scott Beck

text: CornerWorld

text: Ned Timmer

text: Woodland Wireless

text: Woodland Wireless

text: CornerWorld Corporation

text: CornerWorld

text: CornerWorld